Fri, October 6, 2017

by: WOPRAI

Jeffrey Donnelly Maintained (XHR) at Buy and Held Target at $20 on, Oct 6th, 2017

by: WOPRAI

Steve Beuchaw Maintained (XRAY) at Buy with Increased Target to $69 on, Oct 6th, 2017

by: WOPRAI

Lucy Yu Maintained (YUM) at Hold with Increased Target to $45 on, Oct 6th, 2017

by: WOPRAI

Toni Kaplan Maintained (SPGI) at Hold with Increased Target to $158 on, Oct 6th, 2017

by: WOPRAI

David Eads Maintained (WFC) at Hold with Increased Target to $57 on, Oct 6th, 2017

by: WOPRAI

Chris Shaw Maintained (ULH) at Hold with Increased Target to $22 on, Oct 6th, 2017

by: WOPRAI

Dara Mohsenian Maintained (STZ) at Buy with Increased Target to $245 on, Oct 6th, 2017

by: WOPRAI

Mark Swartzberg Maintained (STZ) at Strong Buy with Increased Target to $235 on, Oct 6th, 2017

by: WOPRAI

Kenneth Bruce Downgraded (SYF) to Hold on, Oct 6th, 2017

by: WOPRAI

Matthew Harrison Maintained (BMRN) at Buy with Increased Target to $117 on, Oct 6th, 2017

by: WOPRAI

Marc Goodman Maintained (BMY) at Strong Buy with Increased Target to $72 on, Oct 6th, 2017

by: WOPRAI

Christopher Ellinghaus Downgraded (BKH) to Hold on, Oct 6th, 2017

by: WOPRAI

Allison Poliniak Maintained (WCC) at Buy with Increased Target to $67 on, Oct 6th, 2017

by: WOPRAI

Ricky Goldwasser Downgraded (WBA) to Hold on, Oct 6th, 2017

by: WOPRAI

Steve Beuchaw Maintained (WAT) at Sell with Increased Target to $192 on, Oct 6th, 2017

by: WOPRAI

Phil Gresh Downgraded (VLO) to Hold on, Oct 6th, 2017

Thu, October 5, 2017

by: WOPRAI

Jason Helfstein Initiated (ANGI) at Buy and Held Target at $14 on, Oct 5th, 2017

by: WOPRAI

Nigel Dally Maintained (AMP) at Buy with Increased Target to $162 on, Oct 5th, 2017

by: WOPRAI

Difei Yang Initiated (AKBA) at Strong Buy and Held Target at $24 on, Oct 5th, 2017

by: WOPRAI

Geoffrey Porges Maintained (ABBV) at Buy with Increased Target to $107 on, Oct 5th, 2017

by: WOPRAI

Matthew Clark Initiated (ABCB) at Hold and Held Target at $48 on, Oct 5th, 2017

by: WOPRAI

Mitch Kummetz Initiated (VFC) at Strong Buy and Held Target at $75 on, Oct 5th, 2017

by: WOPRAI

Ravi Shanker Maintained (ARCB) at Hold with Increased Target to $22 on, Oct 5th, 2017

by: WOPRAI

Michael Cyprys Maintained (APO) at Hold with Increased Target to $30 on, Oct 5th, 2017

by: WOPRAI

Jeff Van Sinderen Maintained (ZUMZ) at Strong Buy with Increased Target to $21 on, Oct 5th, 2017

by: WOPRAI

Matthew Harrison Upgraded (BIIB) to Buy on, Oct 5th, 2017

by: WOPRAI

Michael Cyprys Maintained (VRTS) at Hold with Increased Target to $123 on, Oct 5th, 2017

by: WOPRAI

Sherri Scribner Downgraded (WDC) to Hold on, Oct 5th, 2017

by: WOPRAI

Michael Cyprys Upgraded (TROW) to Hold on, Oct 5th, 2017

by: WOPRAI

Michael Cyprys Maintained (BLK) at Buy with Increased Target to $501 on, Oct 5th, 2017

by: WOPRAI

Brad Handler Initiated (TUSK) at Hold and Held Target at $18 on, Oct 5th, 2017

by: WOPRAI

Mitch Kummetz Initiated (UAA) at Hold and Held Target at $17 on, Oct 5th, 2017

Wed, October 4, 2017

by: WOPRAI

PT Luther Maintained (CCJ) at Sell with Increased Target to $29 on, Oct 4th, 2017

by: WOPRAI

Peter Winter Downgraded (TCBI) to Hold on, Oct 4th, 2017

by: WOPRAI

Timna Tanners Maintained (TECK) at Strong Buy with Increased Target to $29 on, Oct 4th, 2017

by: WOPRAI

Douglas Tsao Maintained (TEVA) at Hold with Decreased Target to $21 on, Oct 4th, 2017

by: WOPRAI

Michael Hoffman Downgraded (WM) to Hold on, Oct 4th, 2017

by: WOPRAI

Michael Baudendistel Downgraded (WGO) to Hold on, Oct 4th, 2017

by: WOPRAI

Christian Wetherbee Downgraded (UNP) to Hold on, Oct 4th, 2017

by: WOPRAI

Ryan Gee Initiated (TTWO) at Buy and Held Target at $115 on, Oct 4th, 2017

by: WOPRAI

Romit Shah Initiated (TSLA) at Strong Buy and Held Target at $33 on, Oct 4th, 2017

by: WOPRAI

Kenneth Herbert Maintained (AVAV) at Hold with Increased Target to $48 on, Oct 4th, 2017

by: WOPRAI

Michael Hoffman Maintained (WCN) at Strong Buy with Increased Target to $80 on, Oct 4th, 2017

by: WOPRAI

Jason English Initiated (SMPL) at Strong Buy and Held Target at $16 on, Oct 4th, 2017

by: WOPRAI

Yang Liu Upgraded (VNET) to Buy on, Oct 4th, 2017

by: WOPRAI

Paul Coster Downgraded (VREX) to Sell on, Oct 4th, 2017

by: WOPRAI

Chip Dillion Downgraded (BCC) to Hold on, Oct 4th, 2017

by: WOPRAI

Blayne Curtis Maintained (AMD) at Sell with Increased Target to $10 on, Oct 4th, 2017

Difei Yang Initiated (AKBA) at Strong Buy and Held Target at $24 on, Oct 5th, 2017

Difei Yang of Mizuho, Initiated "Akebia Therapeutics, Inc." (AKBA) at Strong Buy and Held Target at $24 on, Oct 5th, 2017.

Difei, nor any peers, have made any analyst calls on AKBA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30